BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10078630)

  • 1. Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura--a single-institution experience with 189 patients.
    de Graaf-Strukowska L; van der Zee J; van Putten W; Senan S
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):511-6. PubMed ID: 10078630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of radiotherapy in the treatment of malignant pleural mesothelioma.
    Waite K; Gilligan D
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):182-7. PubMed ID: 17359904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of radiotherapy in the treatment of malignant pleural mesothelioma in the chemotherapy era.
    Johnston R; Harrison C; Eakin R; Stewart D; Stranex S; McAleese J
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):630-1. PubMed ID: 17669639
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapy.
    Ball DL; Cruickshank DG
    Am J Clin Oncol; 1990 Feb; 13(1):4-9. PubMed ID: 1689538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of tomotherapy in malignant pleural mesothelioma: first clinical results].
    Giraud P; Sylvestre A; Lisbona A; Zefkili S; Bonnette P; Le Pimpec Barthes F; Michaud JL; Perigaud C; Mahé MA
    Rev Mal Respir; 2011 May; 28(5):609-17. PubMed ID: 21645831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
    Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma.
    Xia H; Karasawa K; Hanyu N; Chang TC; Okamoto M; Kiguchi Y; Kawakami M; Itazawa T
    Int J Hyperthermia; 2006 Nov; 22(7):613-21. PubMed ID: 17079218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma.
    Gupta V; Mychalczak B; Krug L; Flores R; Bains M; Rusch VW; Rosenzweig KE
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1045-52. PubMed ID: 16054774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of palliative radiotherapy in malignant mesothelioma.
    Bissett D; Macbeth FR; Cram I
    Clin Oncol (R Coll Radiol); 1991 Nov; 3(6):315-7. PubMed ID: 1720658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered fractionation of hemithorax irradiation for pleural mesothelioma and failure patterns after treatment.
    Holsti LR; Pyrhönen S; Kajanti M; Mäntylä M; Mattson K; Maasilta P; Kivisaari L
    Acta Oncol; 1997; 36(4):397-405. PubMed ID: 9247101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy.
    Allen AM; Den R; Wong JS; Zurakowski D; Soto R; Jänne PA; Zellos L; Bueno R; Sugarbaker DJ; Baldini EH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1366-74. PubMed ID: 17674974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hemithorax irradiation alone or combined with doxorubicin and cyclophosphamide in 47 pleural mesotheliomas: a nonrandomized phase II study.
    Lindén CJ; Mercke C; Albrechtsson U; Johansson L; Ewers SB
    Eur Respir J; 1996 Dec; 9(12):2565-72. PubMed ID: 8980970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey on the prophylactic as well as symptomatic treatment of intervention sites of malignant pleural mesothelioma in the Netherlands and Belgium.
    van der Zee J; van de Pol M; Praag JO
    Radiother Oncol; 2004 Jan; 70(1):99. PubMed ID: 15036859
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Kristensen CA; Nøttrup TJ; Berthelsen AK; Kjaer-Kristoffersen F; Ravn J; Sørensen JB; Engelholm SA
    Radiother Oncol; 2009 Jul; 92(1):96-9. PubMed ID: 19364621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy.
    Gupta V; Krug LM; Laser B; Hudka K; Flores R; Rusch VW; Rosenzweig KE
    J Thorac Oncol; 2009 Jun; 4(6):746-50. PubMed ID: 19404212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications and limitations of radiotherapy in malignant pleural mesothelioma.
    Senan S
    Curr Opin Oncol; 2003 Mar; 15(2):144-7. PubMed ID: 12601279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Needle-track metastases and prophylactic radiotherapy for mesothelioma.
    West SD; Foord T; Davies RJ
    Respir Med; 2006 Jun; 100(6):1037-40. PubMed ID: 16266800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of malignant pleural mesothelioma].
    Yusa T
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):520-6. PubMed ID: 17431335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: the Heidelberg experience.
    Münter MW; Thieke C; Nikoghosyan A; Nill S; Debus J
    Lung Cancer; 2005 Jul; 49 Suppl 1():S83-6. PubMed ID: 15950807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of pleural mesothelioma].
    Jackevicius A; Cicenas S; Naujokaitis P; Piscikas D
    Medicina (Kaunas); 2002; 38 Suppl 2():79-81. PubMed ID: 12560629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.